Dakota, It is show time for BioCurex. Investors want to see money or deals. There is no mileage left in press releases that talk about additional BioCurex RECAF studies. kag
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.